MOLECULAR VISION

Scope & Guideline

Pioneering insights for a clearer vision of the future.

Introduction

Immerse yourself in the scholarly insights of MOLECULAR VISION with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1090-0535
PublisherMOLECULAR VISION
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1995 to 2024
AbbreviationMOL VIS / Mol. Vis.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressC/O JEFF BOATRIGHT, LAB B, 5500 EMORY EYE CENTER, 1327 CLIFTON RD, N E, ATLANTA, GA 30322

Aims and Scopes

Molecular Vision is a journal dedicated to the dissemination of research in the field of vision science, particularly focusing on the molecular and cellular mechanisms underlying ocular health and disease. The journal aims to provide a platform for innovative research that contributes to the understanding of the pathophysiology of eye diseases and the development of therapeutic strategies.
  1. Molecular Mechanisms in Ocular Diseases:
    The journal publishes research that explores the molecular and cellular basis of various ocular diseases, such as retinitis pigmentosa, diabetic retinopathy, and glaucoma, emphasizing the genetic and biochemical pathways involved.
  2. Innovative Therapeutic Approaches:
    Molecular Vision highlights studies that investigate novel treatment modalities, including gene therapy, stem cell therapy, and pharmacological interventions aimed at restoring vision or preventing vision loss.
  3. Technological Advances in Ocular Research:
    The journal focuses on advancements in imaging technologies, such as optical coherence tomography (OCT) and confocal microscopy, which are essential for visualizing ocular structures and understanding disease progression.
  4. Genetic Studies and Biomarkers:
    Research involving genetic mutations, polymorphisms, and their associations with ocular diseases is prominent, with an emphasis on identifying potential biomarkers for early diagnosis and treatment efficacy.
  5. Inflammatory and Oxidative Stress Responses:
    The journal covers studies that investigate the role of inflammation and oxidative stress in ocular diseases, providing insights into potential therapeutic targets.
Molecular Vision has shown a dynamic evolution in its focus areas, with several emerging themes gaining traction in recent publications. These trends reflect the journal's commitment to addressing contemporary challenges in vision science and ocular health.
  1. Genetic and Genomic Research:
    There is a growing emphasis on genetic studies, including whole exome and genome sequencing, which aim to uncover novel mutations associated with inherited retinal diseases and other ocular conditions.
  2. Molecular Pathways in Disease:
    Research exploring specific molecular pathways, such as the PI3K/Akt pathway and oxidative stress mechanisms, is increasingly common, highlighting the importance of understanding disease mechanisms at a molecular level.
  3. Biomarkers and Precision Medicine:
    The identification of biomarkers for early detection and monitoring of ocular diseases is a prominent trend, with studies focusing on the proteomic and metabolomic profiles of aqueous humor and retinal tissues.
  4. Innovations in Imaging and Monitoring:
    Advanced imaging techniques, including OCT angiography and in vivo confocal microscopy, are gaining popularity for their ability to monitor disease progression and treatment responses in real-time.
  5. Therapeutic Applications of Stem Cells and Regenerative Medicine:
    There is an emerging interest in the application of stem cell therapies and regenerative approaches to treat ocular diseases, reflecting a shift towards innovative treatment strategies.

Declining or Waning

While Molecular Vision continues to thrive in various research domains, certain themes have seen a decline in frequency and emphasis in recent publications. This shift may reflect changing research priorities or advancements in technology and understanding.
  1. Traditional Histopathology Studies:
    Research focused solely on traditional histopathological techniques has decreased, as more studies now incorporate advanced molecular techniques and imaging methods to gain deeper insights into ocular pathologies.
  2. Basic Animal Models:
    There is a noticeable reduction in studies using basic animal models without clear translational relevance. Recent publications favor more sophisticated models that better mimic human disease conditions.
  3. Non-Molecular Therapeutic Approaches:
    Research focusing on conventional therapeutic approaches without molecular or genetic underpinnings has waned, as the field shifts towards precision medicine and targeted therapies.
  4. General Ocular Epidemiology:
    While epidemiological studies are essential, there has been a decrease in general studies that do not incorporate molecular data or genetic analysis, reflecting a trend towards integrating molecular insights into epidemiological research.

Similar Journals

Journal of the Egyptian Ophthalmological Society

Exploring new horizons in eye health and research.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2090-0686Frequency: 4 issues/year

Journal of the Egyptian Ophthalmological Society is a premier academic journal dedicated to advancing the field of ophthalmology through high-quality peer-reviewed research. Published by Wolters Kluwer Medknow Publications, this journal plays a critical role in disseminating vital findings and innovations in eye care, fostering knowledge exchange among researchers, practitioners, and educators worldwide. Since its transformation to Open Access in 2014, it has significantly enhanced the accessibility of eye health information, thereby broadening its impact on the global scientific community. With an ISSN of 2090-0686 and an E-ISSN of 2314-6648, the journal aims to tackle contemporary issues in ophthalmology, including clinical practices, public health, and technological advancements in eye care. The journal's commitment to excellence ensures that it remains a vital resource for those looking to contribute meaningfully to this dynamic and crucial field.

Ophthalmology Science

Pioneering Discoveries in Vision Science
Publisher: ELSEVIERISSN: 2666-9145Frequency:

Ophthalmology Science is a premier journal published by Elsevier, dedicated to advancing the field of ophthalmology through innovative research and clinical insights. With an impact factor that positions it in the Q1 category of ophthalmology journals, it stands out as a crucial resource for researchers, clinicians, and students alike. The journal, indexed under ISSN 2666-9145, covers a wide array of topics relevant to eye care, encompassing the latest breakthroughs in diagnostics, therapeutics, and surgical techniques. Operating in the United States from its office in Amsterdam, the journal aims to bridge the gap between laboratory findings and clinical applications, contributing to improved patient outcomes globally. The converged years from 2021 to 2024 reflect its commitment to providing timely and impactful research that shapes the future of ophthalmic practice. Make sure to explore the open access options available for wider dissemination of your work and to stay ahead in the evolving landscape of ophthalmology.

BRITISH JOURNAL OF OPHTHALMOLOGY

Advancing Vision: Bridging Research and Practice
Publisher: BMJ PUBLISHING GROUPISSN: 0007-1161Frequency: 12 issues/year

The British Journal of Ophthalmology, published by the BMJ Publishing Group, stands as a leading peer-reviewed journal in the field of ocular sciences, with a distinctive focus on advancing the understanding of vision and its impairment. With a rich history dating back to 1941, this journal serves as an essential platform for researchers, professionals, and students in ophthalmology and related disciplines. It prominently ranks in the Q1 quartile for Ophthalmology and Cellular and Molecular Neuroscience in 2023, reflecting its esteemed reputation in the scientific community. The journal boasts impressive Scopus rankings, including Rank #6 in Medicine - Ophthalmology, showcasing its influential contributions to the field. Although it does not offer open access, the journal is committed to disseminating high-quality research that informs clinical practices and enriches the understanding of sensory systems. Submissions are encouraged from all areas of ophthalmology, including clinical studies, innovative research, and systemic reviews. Join the vibrant academic dialogue by engaging with the cutting-edge findings published in the British Journal of Ophthalmology, which aims to bridge the gap between research and clinical application.

Augenheilkunde Up2date

Your Essential Resource for Eye Health Innovations.
Publisher: GEORG THIEME VERLAG KGISSN: 1616-9719Frequency: 4 issues/year

Augenheilkunde Up2date is a pivotal journal in the field of ophthalmology, published by GEORG THIEME VERLAG KG, a renowned publisher known for its commitment to advancing medical knowledge. With its ISSN 1616-9719 and E-ISSN 1616-9735, this journal serves as a vital resource for researchers, professionals, and students interested in the latest developments and nuanced discussions in eye health. Although not available as open access, its curated content offers significant insights into contemporary research, clinical practices, and emerging trends in ophthalmology, thus promoting the continuous professional development of its readers. There is an emphasis on providing comprehensive reviews that encapsulate the pertinent advancements in the field, making it an essential publication for those aiming to enhance their expertise in eye care and vision science.

International Journal of Ophthalmology

Unlocking New Perspectives in Ophthalmology
Publisher: IJO PRESSISSN: 2222-3959Frequency: 12 issues/year

The International Journal of Ophthalmology, with ISSN 2222-3959 and E-ISSN 2227-4898, is a premier open-access publication dedicated to advancing the field of ophthalmology. Published by IJO PRESS in China, this journal has been a valuable resource since its inception in 2005, providing a platform for groundbreaking research and clinical studies in ophthalmic science. With an impressive Q2 ranking in the 2023 Ophthalmology category and a Scopus rank of #65 out of 137, the journal consistently showcases high-quality articles that contribute significantly to the understanding and treatment of eye diseases. Since adopting an open-access model in 2010, it has expanded its reach, allowing researchers, professionals, and students worldwide to access vital knowledge in the field. The journal aims to bridge the gap between laboratory research and clinical practice, making it an essential resource for those committed to improving visual health and advancing ophthalmologic education and innovation.

JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Illuminating the path to ocular health advancements.
Publisher: MARY ANN LIEBERT, INCISSN: 1080-7683Frequency: 10 issues/year

JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, published by Mary Ann Liebert, Inc, stands at the forefront of research in the realms of ophthalmology and pharmacology. Established in 1985 and converging until 2024, this esteemed journal is dedicated to advancing the understanding of ocular pharmacology, drug therapies, and therapeutic approaches in the treatment of eye diseases. With an impressive impact factor and categorized in the Q2 quartile for both Ophthalmology and Medical Pharmacology, it showcases pivotal research in the field, reflecting its rank of #31 among 137 in Ophthalmology and #109 among 272 in Medical Pharmacology per Scopus metrics. Although it follows a subscription-based model, the journal provides critical insights and empirical studies that foster innovation and collaboration for researchers, professionals, and students alike in the pursuit of improving ocular health.

Translational Vision Science & Technology

Pioneering Open Access Research for Visionary Solutions
Publisher: ASSOC RESEARCH VISION OPHTHALMOLOGY INCISSN: 2164-2591Frequency: 6 issues/year

Translational Vision Science & Technology is a premier open access journal dedicated to the advancement of the field of ophthalmology and biomedical engineering. Published by the Association for Research in Vision and Ophthalmology, Inc., this journal has established itself as a leading source of high-quality research since its inception in 2013, achieving a remarkable impact factor reflective of its influential contribution to the field. With an impressive ranking of #21 in Ophthalmology and #120 in Biomedical Engineering within the Scopus database, it sits within the prestigious Q1 quartile for both categories as of 2023, further validating its significance. The journal's scope encompasses a wide variety of topics focused on the intersection of ophthalmological science and technological innovation, welcoming contributions that promote the understanding and treatment of visual disorders. Available as an Open Access publication since 2016, it ensures that cutting-edge research is freely accessible to researchers, practitioners, and students worldwide, facilitating the rapid dissemination of knowledge essential for the advancement of vision science.

Journal of Ophthalmic & Vision Research

Transforming Knowledge into Visionary Solutions
Publisher: KNOWLEDGE EISSN: 2008-2010Frequency: 4 issues/year

The Journal of Ophthalmic & Vision Research, published by KNOWLEDGE E, stands as a crucial platform for disseminating high-quality research in the field of ophthalmology. With an ISSN of 2008-2010 and an E-ISSN of 2008-322X, this journal fosters open access to valuable insights since 2010, enhancing visibility and reach for researchers globally. Based in Dubai, UAE, it has established a reputation for excellence, reflected in its Q2 ranking in Ophthalmology for 2023 and its position among the top 65th percentile in Scopus. Covering a broad spectrum of topics within ophthalmic science, the journal serves as a vital resource for professionals, researchers, and students by presenting original research, reviews, and case studies that drive innovation and collaboration within the community. As the journal continues to contribute to advancements in eye care and vision sciences, it invites scholars to explore, engage, and publish within its pages, thus enriching the global discourse on ophthalmic health.

Ocular Surface

Illuminating Insights in Ophthalmology
Publisher: ELSEVIERISSN: 1542-0124Frequency: 4 issues/year

Ocular Surface, published by Elsevier, stands at the forefront of ophthalmology research, with a notable Impact Factor reflecting its significant contribution to the field. As a vibrant platform for disseminating cutting-edge findings, this journal has achieved Q1 ranking in the Ophthalmology category as of 2023, placing it amongst the top-tier journals globally, specifically ranking 4th out of 137 in Scopus with an impressive 97th percentile. Spanning across the years from 2003 to 2024, Ocular Surface focuses on advancing knowledge in areas such as ocular pathology, therapy, and surgical interventions. While the journal is not open access, it provides invaluable insights and empirical data essential for researchers, professionals, and students dedicated to improving ocular health. With an address rooted in Amsterdam, Netherlands, this esteemed journal continues to enrich the global conversation in ophthalmology.

JOURNAL FRANCAIS D OPHTALMOLOGIE

Advancing ocular health through innovative research.
Publisher: MASSON EDITEURISSN: 0181-5512Frequency: 10 issues/year

JOURNAL FRANCAIS D OPHTALMOLOGIE, published by MASSON EDITEUR, is a prominent peer-reviewed journal that serves as a vital resource in the field of ophthalmology. Launched in 1978, this esteemed publication continues to make significant contributions to the advancement of ocular health and vision science, with its scope encompassing clinical practices, innovative research, and the latest technological advancements in ophthalmic care. Based in France, the journal is recognized in the 2023 category quartiles with a Q3 ranking in ophthalmology, reflecting its dedication to quality scholarship within a competitive landscape, as evidenced by its positioning in the 30th percentile of the Scopus rankings. While it operates without Open Access, the journal remains crucial for professionals, researchers, and students alike, providing a platform for sharing knowledge and fostering collaborations in the global ophthalmological community.